ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-80
SponsorInstitute of Automation, Chinese Academy of Sciences

About this trial

In this study, the investigators will detect hepatocellular carcinoma lesions using fluoescence imaging with ITGA6 targeting probes during tumor resection surgery. The aim is to evaluate wether intraoperative fluorescence imaging targeting ITGA6 can help to improve the detction effect of hepatocellular carcinoma, and finally help the accurate surgical resection.

The main purposes of this study include:

1. To raise the detection rate of hepatocellular carcinoma intraoperatively using the novel NIR-II fluorescence molecular imaging and the ITGA6 targeting probe. 2. To validate the safety and effectiveness of the proposed ITGA6 targeting probes for clinical application.

Eligibility criteria

Qualifiers

Patients who have been diagnosed with hepatocellular carcinoma.

Planned to receive hepatectomy.

Liver function Child-Pugh A.

ITGA6 was validated highly expressed preoperatively.

Disqualifiers

Allergic to Cy7.

Enrolled in other trials in the past 3 months.

Another malignant tumor was found.

Undesirable function of heart, lung, kidney, or any other organs.

Trial design

Treatments tested in this trial

  • RD-Cy7 fluorophore

Treatment groups

90 Participants
are divided into 1 treatment group